Strategic leverage MKO Global Partners specializes in payer strategy, market access and pricing for pharma and biotech, and since their acquisition by Two Labs, can offer a broader portfolio across the product lifecycle. This positions them to cross-sell integrated value and access services to clients seeking end-to-end commercial readiness.

Global scale access As a Two Labs subsidiary with a global life sciences consulting footprint, MKO can pursue opportunities with mid-market and multinational pharma companies seeking unified payer strategy and market access expertise across regions, potentially expanding into new geographies through existing corporate infrastructure.

Lifecycle growth Their focus on commercialization, payer strategy and market access aligns with companies tackling late-stage optimization, pricing strategy, and reimbursement hurdles, presenting upsell opportunities to clients navigating launches, line extensions, or portfolio optimizations.

Financial foothold Reported revenue between 1M and 10M with a small team, implying high value per engagement. This suggests opportunities to pursue larger, multi-project contracts with existing clients and to upsell extended services as client budgets and programs grow.

Acquisition advantage Being part of Two Labs since 2018 provides a credibility boost and potential co-selling opportunities with a broader pharma services platform, enabling joint outreach to target buyers familiar with Two Labs’ full suite and historical client success.